 |
 |

Vasoconstrictor and Systemic Activities of Topical Steroids
K. J. Child, PhD;
A. F. English, B Pharm;
H. G. Gilbert, BSc;
Anthonia Hewitt, BSc;
E. A. Woollett, MIBiol
Arch Dermatol. 1968;97(4):407-410.
Abstract
Six commercially available topical steroid preparations have been examined for vasoconstrictor activity in man, for systemic anti-inflammatory activity in mice and rats, for progestational activity in rabbits. Good agreement was shown between "ranking order" of topical activity and "ranking order" of systemic activity with the exceptions that betamethasone had a lower, and betamethasone valerate had a higher, topical ranking than would have been expected from their systemic activities in the rat.
Author Affiliations
Buckinghamshire, England
From Glaxo Research, Ltd, Fulmer Hall, Fulmer, Buckinghamshire, England.
Footnotes
Accepted for publication June 23, 1967.
Reprint requests to Glaxo Research Ltd, Fulmer Hall, Fulmer, Buckinghamshire, England.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Paired Comparison Vasoconstrictor Assays: A Comparison of Methods for the Determination of Relative Vasoconstrictor Potency of Topically Applied Corticosteroids
Poulsen et al.
Arch Dermatol 1974;109:367-371.
ABSTRACT
Precise Evaluation of Topically Applied Corticosteroid Potency: Modification of the Stoughton-McKenzie Assay
Place et al.
Arch Dermatol 1970;101:531-537.
ABSTRACT
Suppression of Raynaud's Phenomenon by Methyldopa
Varadi and Lawrence
Arch Intern Med 1969;124:13-18.
ABSTRACT
VASOCONSTRICTOR AND SYSTEMIC ACTIVITIES OF TOPICAL STERIODS-Reply
Child et al.
Arch Dermatol 1968;98:685-686.
ABSTRACT
|